Q4 2015 13F Holders as of 31 Dec 2015
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
12,216,344
-
Share change
-
+312,319
-
Total reported value
-
$40,067,000
-
Price per share
-
$3.28
-
Number of holders
-
31
-
Value change
-
+$1,025,847
-
Number of buys
-
15
-
Number of sells
-
10
Institutional Holders of TENAX THERAPEUTICS INC - COM (TENX) as of Q4 2015
As of 31 Dec 2015,
TENAX THERAPEUTICS INC - COM (TENX) was held by
31 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
12,216,344 shares.
The largest 10 holders included
SABBY MANAGEMENT, LLC, RA CAPITAL MANAGEMENT, LLC, Broadfin Capital, LLC, GREAT POINT PARTNERS LLC, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Opaleye Management Inc., BAKER BROS. ADVISORS LP, COMMERZBANK AKTIENGESELLSCHAFT /FI, and Bank of New York Mellon Corp.
This page lists
31
institutional shareholders reporting positions in this security
for the Q4 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.